Promising vaccine could treat two deadliest and fastest-rising forms of cancer, early study shows
A phase 1, first-in-human trial showed that an off-the-shelf vaccine lowered the risk of relapse in patients with colon and pancreatic cancer. It does this by attacking the KRAS mutation in the cancers.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Colon Cancer | Colorectal Cancer | Health | Pancreas | Pancreatic Cancer | Study | Vaccines